PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25071015-0	2014	p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.	Glucose	79-86	tumor protein p53	Homo sapiens	0-3	
25071015-9	2014	In the early setting, data suggested longer disease free survival in p53 negative patients in the lowest glucose category (p=0.053).	Glucose	105-112	tumor protein p53	Homo sapiens	69-72